Publications by authors named "Timea Balatoni"

Claim this Profile
[
[Immunotherapy of cutaneous neoplasms].
Luca Ambrus, Tímea Balatoni

Magy Onkol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective Study.
Gitta Pánczél, Patrik Horváth, Erijona Temaj, Kata Czirbesz, Mihály Tamás Kispál, Tímea Balatoni

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.
Barbara Hegyi, Kristóf György Csikó, Tímea Balatoni, Georgina Fröhlich, Katalin Bőcs

Biomolecules· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Electrochemotherapy in metastatic melanoma].
Mihály Kispál, Kata Czirbesz, Fanni Baranyai, Tímea Balatoni, Gabriella Liszkay

Orv Hetil· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients.
Grethe Eikenes, Gabriella Liszkay, Tímea Balatoni, Kata Czirbesz, Karen Hunyadi

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report.
Zsófia Küronya, Tímea Danyi, Tímea Balatoni, Gabriella Liszkay, Erika Tóth

J Med Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients.
Mihály Kispál, Levente Zsolt Jánváry, Tímea Balatoni, Stelczer Gábor, Imre Fedorcsák

Pathol Oncol Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[BRAF-MEK inhibitor therapy in melanoma].
Kata Czirbesz, Gitta Pánczél, Fanni Baranyai, Mihály Kispál, Erika Tóth, Tímea Balatoni

Magy Onkol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Actual points of melanoma management].
Gabriella Liszkay, Tímea Balatoni

Magy Onkol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[COVID-19 and melanoma: a single center retrospective cohort study from Hungary].
Tímea Balatoni, Mihály Kispál, Ildikó Madurka, Gabriella Liszkay

Magy Onkol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab.
Andrea Ladányi, Barbara Hegyi, Tímea Balatoni, Gabriella Liszkay, Raphael Rohregger

Pathol Oncol Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Karen Hunyadi, Nóra Nádudvari, Mihály Kispál, Tímea Balatoni, Ildikó Madurka

Magy Onkol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma.
Andrea Ladányi, Eszter Papp, Anita Mohos, Tímea Balatoni, Gabriella Liszkay

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.
Tímea Balatoni, Andrea Ladányi, Georgina Fröhlich, Kata Czirbesz, Péter Kovács

Pathol Oncol Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data.
Kata Czirbesz, Eszter Gorka, Tímea Balatoni, Gitta Pánczél, Krisztina Melegh

Pathol Oncol Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours.
Beatrix Kotlan, Vanda Plotar, Klara Eles, Szabolcs Horvath, Timea Balatoni

Contemp Oncol (Pozn)· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy.
Tímea Balatoni, Anita Mohos, Eszter Papp, Tímea Sebestyén, Gabriella Liszkay

Cancer Immunol Immunother· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies, Gennaro Ciliberto, Timea Balatoni

J Transl Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Psychological aspects of immunotherapies in the treatment of malignant melanoma].
Péter Kovács, Gitta Pánczél, Krisztina Melegh, Tímea Balatoni, Edit Pörneczy

Magy Onkol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients.
Péter Kovács, Gitta Pánczél, Tímea Balatoni, Gabriella Liszkay, Xenia Gonda

J Psychosom Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value.
Beatrix Kotlan, Gabriella Liszkay, Miri Blank, Orsolya Csuka, Timea Balatoni

Immunol Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Unblocking antitumor immune response: novel possibilities for the immunotherapy of melanoma].
Andrea Ladányi, Tímea Balatoni

Magy Onkol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The importance of fine needle aspiration cytology in the management of recurrent and metastatic melanoma].
Gitta Pánczél, Gabriella Liszkay, Kinga Borbola, Tímea Balatoni, János Hunyadi

Orv Hetil· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Epidemiology of malignant melanoma (Clinical experience at the National Institute of Oncology in Hungary)].
Tímea Balatoni, Gabriella Liszkay, Zoltánné Miklós, Miklós Kásler

Orv Hetil· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis